Evidence map›Paper›PMID 20535639›Full record

ArticleMycopathologia2010

The utility of Coccidioides polymerase chain reaction testing in the clinical setting.

Darko Vucicevic, Janis E Blair, Matthew J Binnicker, Ann E McCullough, Shimon Kusne, Holenarasipur R Vikram, James M Parish, Nancy L Wengenack

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Overview of the Current Challenges in Pulmonary Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2024
    Review
  3. Review
  4. Neurococcidiomycosis in children with hydrocephalus: assessment of functional outcome, quality of life and survival in relation to neuroimaging findings.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Observational
  5. Review
  6. Review
  7. Review
  8. Review
  9. Coccidioidomycosis: A Contemporary Review.Infectious diseases and therapy · 2022
    Review
  10. Article
  11. Article
  12. Primary Cutaneous Coccidioidomycosis: An Update.American journal of clinical dermatology · 2020
    Review
  13. Central Nervous System Infections Due to Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2019
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. The public health impact of coccidioidomycosis in Arizona and California.International journal of environmental research and public health · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Darko VucicevicDivision of Infectious Diseases, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
Janis E Blair
Matthew J Binnicker
Ann E McCullough
Shimon Kusne
Holenarasipur R Vikram
James M Parish
Nancy L Wengenack
Mayo Clinic in Arizona · USMayo Clinic · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coccidioidomycosis, the fungal infection caused by dimorphic Coccidioides sp., is typically diagnosed by histopathologic identification of spherules in affected secretions and tissues or by culture. These tests are reliable but time-intensive, delaying diagnosis and treatment. To evaluate a polymerase chain reaction (PCR) test developed to detect Coccidioides sp. in clinical specimens, we conducted a retrospective chart review of all patients (N = 145) who underwent Coccidioides PCR at our institution between April 27, 2007, and May 6, 2008, abstracting clinical, microbiologic, serologic, radiographic, treatment, and follow-up data. One hundred fifty-eight PCR tests (153 respiratory; 5 cerebrospinal fluid) produced 5 positive and 153 negative findings. Five of nine patients (56%) with confirmed or highly probable pulmonary coccidioidomycosis had a positive PCR on respiratory specimens, and four of nine (44%) had a positive culture. Among two patients with coccidioidal meningitis, none had a positive PCR, whereas Coccidioides sp. in fungal culture grew for one of two. Among six asymptomatic patients with probable coccidioidomycosis, none had a positive culture or PCR. Compared with culture of respiratory specimens, PCR demonstrated a sensitivity, specificity, positive predictive value, and negative predictive value of 75, 99, 60, and 99%, respectively. Coccidioides PCR appears accurate in identifying negative results, and its sensitivity is similar to that of fungal culture.

Indexed as

Clinical Laboratory TechniquesCoccidioidesCoccidioidomycosisHumansMycologyPolymerase Chain ReactionPredictive Value of TestsRetrospective StudiesSensitivity and Specificity

Identifiers

PMID20535639
OpenAlexW2009594050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.